(Q34655559)

3 August 2017

title

Frovatriptan: a review of drug-drug interactions (English)

1 reference

3 August 2017

0 references

Buchan P

1

1 reference

3 August 2017

Wade A

2

1 reference

3 August 2017

Ward C

3

1 reference

3 August 2017

Oliver SD

4

1 reference

3 August 2017

Stewart AJ

5

1 reference

3 August 2017

Freestone S

6

1 reference

3 August 2017

publication date

1 April 2002

1 reference

3 August 2017

1 reference

3 August 2017

volume

42 Suppl 2

1 reference

3 August 2017

page(s)

S63-73

1 reference

Effects of the novel high-affinity 5-HT(1B/1D)-receptor ligand frovatriptan in human isolated basilar and coronary arteries

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.42.S2.4.X

Clinical pharmacokinetics of frovatriptan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.42.S2.4.X

Multimodal event-related potential P3 after transient global amnesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.42.S2.4.X

Potential drug interactions with the novel antimigraine compound zolmitriptan (Zomig, 311C90)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.42.S2.4.X

Impairment of caffeine clearance by chronic use of low-dose oestrogen-containing oral contraceptives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.42.S2.4.X

The effects of moclobemide on the pharmacokinetics of the 5-HT1B/1D agonist rizatriptan in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.42.S2.4.X

Effect of the progestogens, gestodene, 3-keto desogestrel, levonorgestrel, norethisterone and norgestimate on the oxidation of ethinyloestradiol and other substrates by human liver microsomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.42.S2.4.X

Inhibition of oral contraceptive steroid-metabolizing enzymes by steroids and drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.42.S2.4.X

Moclobemide, a substrate of CYP2C19 and an inhibitor of CYP2C19, CYP2D6, and CYP1A2: A panel study*

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.42.S2.4.X

10.1046/J.1526-4610.42.S2.4.X

21 January 2018

Identifiers

DOI

1 reference

release_vmvn5j6svff7xi2c2snawffg6u

3 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/vmvn5j6svff7xi2c2snawffg6u

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference